Adding 10 years to healthy lifespan
Retro Biosciences (retro.bio) earns a Brand Analyzer score of 74 out of 100, placing it in the Brand-Ready tier among Healthcare brands, Other brands. Among 4769 Healthcare brands analyzed, Retro Biosciences ranks in the 49th percentile (category average 74, leader 96). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 85/100, Digital Presence 96/100, Visual Identity 95/100, Messaging Clarity 95/100, Trust Foundation 60/100, AI Discoverability 85/100, Brand Authority 32/100.
Retro Biosciences is a San Francisco-based biotechnology company focused on aging biology, with the stated mission of developing therapies to extend healthy human lifespan by ten years. The company applies tools such as single-cell multi-omics and targeted delivery systems to identify cellular drivers of aging, aiming to translate interventions proven in mammalian models into human therapeutics that prevent and reverse age-related diseases rather than treat individual symptoms.
| Brand Name | Retro Biosciences |
|---|---|
| Domain | retro.bio |
| Industry | Healthcare, Other |
| Headquarters | San Francisco |
| Main Competitors | Altos Labs (82/100), Calico Life Sciences (85/100), Unity Biotechnology (60/100), BioAge Labs (74/100), Life Biosciences, NewLimit |
Moz Domain Authority 40/100 vs category average 38 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #2,200,344 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
Retro Biosciences appears on Wikipedia but without a dedicated company entity, so AI models can confuse it with similarly named subjects.
The homepage meta description reads "Retro Biosciences develops therapies that target aging biology to extend healthy human lifespan by 10 years." (Meta description: 16 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 2 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Next.js, Vercel.
Social footprint: verified profiles on X (Twitter), LinkedIn, Instagram, GitHub; no detected presence on Facebook, YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Retro Biosciences scores 46/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Retro Biosciences has a limited AI-visibility profile at 46/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (53/100) and its weakest is visibility (39/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #2,200,344 (Tranco) and a Moz Domain Authority of 40/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Retro Biosciences from memory (August 2026) - a sign these signals are paying off.
Live results from asking a general-purpose AI assistant about the brand, checked August 2026.
When asked "What is Retro Biosciences?", Claude could identify the brand as of August 2026. Retro Biosciences is a longevity biotech startup founded by Joe Betts-LaCroix that aims to add 10 healthy years to human lifespan, working on areas like cellular reprogramming, plasma-derived therapeutics, and autophagy. Best known for Being a well-funded longevity/anti-aging biotech backed by a large investment from Sam Altman.
When asked "Best brands similar to Retro Biosciences?", Claude would recommend Retro Biosciences as of August 2026. It's one of the most prominent and well-capitalized companies in the longevity biotech space, so it's relevant when discussing leaders in that field.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Retro Biosciences's main competitors include Altos Labs (82/100), Calico Life Sciences (85/100), Unity Biotechnology (60/100), BioAge Labs (74/100), Life Biosciences. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Brand Analyzer scan
Retro Biosciences and Calico Life Sciences are competitors in Healthcare. Brand Analyzer scores Retro Biosciences at 74/100 and Calico Life Sciences at 85/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Brand Analyzer scan
Popular alternatives to Retro Biosciences include Altos Labs (82/100), Calico Life Sciences (85/100), Unity Biotechnology (60/100), BioAge Labs (74/100), Life Biosciences. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Brand Analyzer scan
Retro Biosciences has limited AI-search visibility, scoring 46/100 on Brand Analyzer's AI visibility composite (visibility 39, trust 52, recommendation 53). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Retro Biosciences official site
Retro Biosciences is headquartered in San Francisco. Retro Biosciences operates in the Healthcare category.
Sources: Wikidata
Retro Biosciences scores 53/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Retro Biosciences official site
Retro Biosciences is an American biotechnology company headquartered in San Francisco that develops therapies targeting the biological mechanisms of aging. Its stated mission is to extend healthy human lifespan by ten years through science-driven interventions aimed at the root causes of age-related disease.
Sources: Retro Biosciences official site
Retro Biosciences researches and develops therapeutic approaches that target the cellular and molecular drivers of aging. The company uses techniques such as single-cell multi-omics analysis and targeted delivery systems to study aging biology and to translate interventions that have shown promise in mammalian models into potential human treatments aimed at preventing and reversing age-related diseases.
Sources: Retro Biosciences official site
Retro Biosciences can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Retro Biosciences official site
Retro Biosciences is known for its explicit mission to extend healthy human lifespan by ten years and for positioning itself as a company that targets the underlying biological mechanisms of aging rather than treating individual age-related symptoms or diseases separately.
Sources: Retro Biosciences official site
Retro Biosciences' work is oriented toward scientists, healthcare stakeholders, investors, and individuals interested in longevity research and extending healthy human lifespan, according to its stated target audience.
Sources: Retro Biosciences official site
Ranked closest to Retro Biosciences: Re-engage (74/100), Redesign Health (74/100), Reverba (74/100), Revian (74/100).
A step up - brands to learn from: Zurich Insurance Group (81/100), Zimmer Biomet (81/100).
Category leader: Elsevier (96/100).